Company: SHPH
Filing Date: 2025-11-07
Form Type: 8-K
Source: 0001493152-25-021256
Chunk: 1

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-11-07
Form: 8-K
Item: Item 1.01
Chunk 1
---
 “ Securities Act”),
or any state securities laws. The Pre-Funded Warrant was issued in reliance on the exemption from registration provided by Section 4(a)(2)
under the Securities Act and/or Regulation D promulgated thereunder for transactions not involving a public offering.

Pursuant
to the Purchase Agreement, the Company has agreed not to issue, enter into any agreement to issue, or announce the issuance or proposed
issuance of any shares of Common Stock or Common Stock equivalents, or file any registration statement or any amendment or supplement
thereto, other than as contemplated by the Purchase Agreement, from the date of the closing of the Offering and for a period of fifteen
(15) days thereafter.

The
Purchase Agreement contains customary representations, warranties and agreements by the Company, and indemnification obligations of the
Company and the Purchaser, and other obligations of the parties. The representations, warranties and covenants contained in the Purchase
Agreement were made only for purposes of such Purchase Agreement and are made as of specific dates; are solely for the benefit of the
parties (except as specifically set forth therein); may be subject to qualifications and limitations agreed upon by the parties in connection
with negotiating the terms of the Purchase Agreement, instead of establishing matters as facts; and may be subject to standards of materiality
and knowledge applicable to the contracting parties that differ from those applicable to investors generally. Investors should not rely
on the representations, warranties and covenants or any description thereof as characterizations of the actual state of facts or condition
of the Company.

Placement
Agency Agreement

The
Company entered into a Placement Agency Agreement with the Placement Agent, dated November 3, 2025, pursuant to which the Placement Agent
agreed to act as the exclusive placement agent for the Company in connection with the Offering (the “ Placement Agency Agreement”).
Pursuant to the Placement Agency Agreement, the Company paid the Placement Agent a cash fee of 4% of the gross proceeds from the Offering.

The
Placement Agency Agreement contains customary representations, warranties, and agreements by the Company, customary conditions to closing,
indemnification obligations of the Company, other obligations of the parties, and termination provisions.